DETECTION METHOD FOR PRESENCE OF DISEASE INVOLVING GLO1 EXPRESSION, MARKER USED IN THE DETECTION METHOD, GLO1 ENZYME ACTIVITY IMPROVER, AND GLO1 ENZYME ACTIVITY REDUCING AGENT

PROBLEM TO BE SOLVED: To provide a method for detecting a disease involving the expression of GLO1 by analyzing details of the expression of GLO1, a marker used in the detection method, a GLO1 enzyme activity improver, and a GLO1 enzyme activity reducing agent.SOLUTION: According to the present inve...

Full description

Saved in:
Bibliographic Details
Main Authors TAKAYAMA HIDEO, FUSHIDA NATSUMI, MUNEI SEIICHI, YOKOYAMA RINA, UCHIGATA YASUKO, MIURA JUNNOSUKE, YAMAMOTO YASUHIKO, YAMAMOTO HIROSHI, YAMAMURA YUKA, HARASHIMA AI
Format Patent
LanguageEnglish
Japanese
Published 16.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide a method for detecting a disease involving the expression of GLO1 by analyzing details of the expression of GLO1, a marker used in the detection method, a GLO1 enzyme activity improver, and a GLO1 enzyme activity reducing agent.SOLUTION: According to the present invention, there are provided a method, etc., based on the finding that there are 8 different gene polymorphisms present in the thymine repeat sequence within the GLO1 promoter region, a gene polymorphism with 15 thymines is involved in the enhancement of GLO1 transcriptional activity, and the proportion of the gene polymorphism correlates with a disease involving the expression of GLO1.SELECTED DRAWING: None 【課題】GLO1の発現の詳細を解析して、GLO1の発現が関与する疾患の検出方法、該検出方法に使用するマーカー、GLO1酵素活性向上剤及びGLO1酵素活性低減剤を提供すること。【解決手段】GLO1プロモーター領域内のチミン反復配列内に存在する8種類の遺伝子多型が存在すること、チミン数15個の遺伝子多型がGLO1の転写活性の亢進に関与すること、さらには該遺伝子多型割合がGLO1の発現が関与する疾患と相関することを新規に見出し、本発明を完成した。【選択図】なし
AbstractList PROBLEM TO BE SOLVED: To provide a method for detecting a disease involving the expression of GLO1 by analyzing details of the expression of GLO1, a marker used in the detection method, a GLO1 enzyme activity improver, and a GLO1 enzyme activity reducing agent.SOLUTION: According to the present invention, there are provided a method, etc., based on the finding that there are 8 different gene polymorphisms present in the thymine repeat sequence within the GLO1 promoter region, a gene polymorphism with 15 thymines is involved in the enhancement of GLO1 transcriptional activity, and the proportion of the gene polymorphism correlates with a disease involving the expression of GLO1.SELECTED DRAWING: None 【課題】GLO1の発現の詳細を解析して、GLO1の発現が関与する疾患の検出方法、該検出方法に使用するマーカー、GLO1酵素活性向上剤及びGLO1酵素活性低減剤を提供すること。【解決手段】GLO1プロモーター領域内のチミン反復配列内に存在する8種類の遺伝子多型が存在すること、チミン数15個の遺伝子多型がGLO1の転写活性の亢進に関与すること、さらには該遺伝子多型割合がGLO1の発現が関与する疾患と相関することを新規に見出し、本発明を完成した。【選択図】なし
Author YOKOYAMA RINA
YAMAMOTO YASUHIKO
HARASHIMA AI
UCHIGATA YASUKO
YAMAMURA YUKA
MIURA JUNNOSUKE
FUSHIDA NATSUMI
MUNEI SEIICHI
YAMAMOTO HIROSHI
TAKAYAMA HIDEO
Author_xml – fullname: TAKAYAMA HIDEO
– fullname: FUSHIDA NATSUMI
– fullname: MUNEI SEIICHI
– fullname: YOKOYAMA RINA
– fullname: UCHIGATA YASUKO
– fullname: MIURA JUNNOSUKE
– fullname: YAMAMOTO YASUHIKO
– fullname: YAMAMOTO HIROSHI
– fullname: YAMAMURA YUKA
– fullname: HARASHIMA AI
BookMark eNqNjb0KwjAcxDvo4Nc7_HGu4CfiGJprG7VJSdJiXUqROElb0PfyFa3gJA4Oxw33u7uh16ub2g28J4dFYIWSlMDGilOoNKUaBjIAqZC4MGAGJGSujrmQEUVHtSCc3pDpij4lTB-gKTPgHUY2Bn3P-p-WPBcJiHVRLmxBIkm1yqF9YpL_RjR4FrxvWQRpx17_Wt3ubvLxkTcNYYN45tqmdPe2urjaPcp9upwvtp126w1b_QW9AMjqSto
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate GLO1の発現が関与する疾患の存在の検出方法、該検出方法に使用するマーカー、GLO1酵素活性向上剤及びGLO1酵素活性低減剤
ExternalDocumentID JP2017201945A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2017201945A3
IEDL.DBID EVB
IngestDate Fri Jul 19 17:04:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2017201945A3
Notes Application Number: JP20160096027
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171116&DB=EPODOC&CC=JP&NR=2017201945A
ParticipantIDs epo_espacenet_JP2017201945A
PublicationCentury 2000
PublicationDate 20171116
PublicationDateYYYYMMDD 2017-11-16
PublicationDate_xml – month: 11
  year: 2017
  text: 20171116
  day: 16
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies TOKYO WOMEN'S MEDICAL COLLEGE
KANAZAWA UNIV
RelatedCompanies_xml – name: KANAZAWA UNIV
– name: TOKYO WOMEN'S MEDICAL COLLEGE
Score 3.2365203
Snippet PROBLEM TO BE SOLVED: To provide a method for detecting a disease involving the expression of GLO1 by analyzing details of the expression of GLO1, a marker...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
Title DETECTION METHOD FOR PRESENCE OF DISEASE INVOLVING GLO1 EXPRESSION, MARKER USED IN THE DETECTION METHOD, GLO1 ENZYME ACTIVITY IMPROVER, AND GLO1 ENZYME ACTIVITY REDUCING AGENT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171116&DB=EPODOC&locale=&CC=JP&NR=2017201945A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFG4Qr2-KGhU1jTF7YtG5G3sgZqwdG7JLxljAF0K3kagJEJnxZ_kXbZuhxBge9rD29DT5lrPTnn7nFIDbJpFYCZmmqKdaJirUYYhGU1VE4yHLFZlo8oSwbGTP15yB0h2qwwp4W-XC8Dqhn7w4IrWolNp7wf_Xi98gFuLcyuUdeaFN80c7biGh3B1LOjVdTUDtFg4DFFiCZbW6oeBHvI8-hqKaW2CbrqN1xv_CSZulpSzWfYp9CHZCqm5WHIHK66QG9q3V1Ws1sOeVJ941sMspmumSNpZmuDwGXwjHmLM_oIdjJ0CQ7uUgA5MFjGBgQ-T2sdnH0PWToJe4fgd2eoEE8ZAjTgc2oGdGTziCgz5GVAzGDoZ_1TbKUf7zyMOQ8U0SNx5B1wujIMFRA5o--l8kYjf6sGnNDvbjE3Bj49hyRIrB-AfxcTdcw0s-BdXZfJafASgpKsnVlK7hsntlShSSSZmkT6lkphJjIp-D-gZFFxt76-CAvbE8P0m7BNXi_SO_og6_INf8Q30DueSg3A
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD5BvOCbokbFS2MMTyw6dwEeiBlrxwbskjEX8IXQbSRqAkQw_iz_om0DSozhoS89p6fJ15yeXs4F4LZGZZ5CpiZVEz2VVGYwpHpNU6X6Q5qpCtWVEeXRyK6n209qu6_1c_C2ioUReUI_RXJEplEJ0_eF2K9nv49YWPhWzu_oC-uaPlpRA5eXt2O5ylRXL-NmgwQ-9s2yaTbaQdkLBY21uqoZW7DNztg1nmifxE0eljJbtynWAewETNxkcQi511ERCuaq9FoR9tzlj3cRdoWLZjJnnUs1nB_BFyYREd4fyCWR7WPE7nKIg8kfjJBvIez0iNEjyPFivxs7Xgu1ur6MSF8gzgZWkGuEHRKipx7BjA1FNkF_xVaWo7zngUsQ9zeJnWiAHDcI_ZiEFWR4-H-WkFf04dMaLeJFx3Bjkci0JYbB8AfxYTtYw0s5gfxkOslOAcmqRjMtYWe49F4dU5WmcipXx4wz1Wh9pJxBaYOg843UayjYkdsddh2vU4J9TuExf7J-AfnF-0d2yYz_gl6JRfsGb9SjzA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DETECTION+METHOD+FOR+PRESENCE+OF+DISEASE+INVOLVING+GLO1+EXPRESSION%2C+MARKER+USED+IN+THE+DETECTION+METHOD%2C+GLO1+ENZYME+ACTIVITY+IMPROVER%2C+AND+GLO1+ENZYME+ACTIVITY+REDUCING+AGENT&rft.inventor=TAKAYAMA+HIDEO&rft.inventor=FUSHIDA+NATSUMI&rft.inventor=MUNEI+SEIICHI&rft.inventor=YOKOYAMA+RINA&rft.inventor=UCHIGATA+YASUKO&rft.inventor=MIURA+JUNNOSUKE&rft.inventor=YAMAMOTO+YASUHIKO&rft.inventor=YAMAMOTO+HIROSHI&rft.inventor=YAMAMURA+YUKA&rft.inventor=HARASHIMA+AI&rft.date=2017-11-16&rft.externalDBID=A&rft.externalDocID=JP2017201945A